Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Single-center Clinical Trial to Evaluate the Anti-gastroesophageal Reflux Effect of Anvitra Gastric Suspension Health Supplements on Outpatients With Gastroesophageal Reflux at Hai Phong Medical University Hospital in 2024

NCT06889246 is registered in ClinicalTrials.gov with Haiphong University of Medicine and Pharmacy as lead sponsor.

NCT NCT06889246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06889246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Single-center Clinical Trial to Evaluate the Anti-gastroesophageal Reflux Effect of Anvitra Gastric Suspension Health Supplements on Outpatients With Gastroesophageal Reflux at Hai Phong Medical University Hospital in 2024
Lead sponsor
Haiphong University of Medicine and Pharmacy
Phase
Not applicable
Overall status
Completed
Start date
August 6, 2024
Completion date
December 30, 2024
Enrollment
27 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gerd (heartburn, regurgitation, and dyspepsia) frequency, gerd (heartburn, regurgitation, and dyspepsia) severity